Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Non-Current Assets of $551.0 million in Q1 2026, up 1.41% quarter-over-quarter from $543.4 million in Q4 2025, and up 1.81% on a YoY basis from $541.2 million in Q1 2025.
Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Non-Current Assets history runs 14 years deep, the most recent figure standing at $551.0 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 1.81% year-over-year to $551.0 million; the TTM figure through Mar 2026 stood at $2.2 billion (up 18.15% YoY), while the FY2025 annual figure was $550.3 million, up 44.36% from the prior year.
- Non-Current Assets was $551.0 million for Q1 2026 at Phibro Animal Health, up from $543.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $551.0 million in Q1 2026 to a low of $365.5 million in Q2 2022.
- Historically, Non-Current Assets has averaged $438.8 million across 5 years, with a median of $385.7 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets dropped 1.16% in 2024, then jumped 44.36% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $380.1 million in 2022, then rose by 1.57% to $386.1 million in 2023, then soared by 39.69% to $539.4 million in 2024, then rose by 0.74% to $543.4 million in 2025, then rose by 1.41% to $551.0 million in 2026.
- The last three Non-Current Assets figures came in at $551.0 million (Q1 2026), $543.4 million (Q4 2025), and $549.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 551.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551.05 Mn |
| Dec 31, 2025 | 543.37 Mn |
| Sep 30, 2025 | 549.73 Mn |
| Jun 30, 2025 | 550.29 Mn |
| Mar 31, 2025 | 541.24 Mn |
| Dec 31, 2024 | 539.36 Mn |
| Sep 30, 2024 | 395.52 Mn |
| Jun 30, 2024 | 381.19 Mn |
| Mar 31, 2024 | 381.86 Mn |
| Dec 31, 2023 | 386.12 Mn |
| Sep 30, 2023 | 380.10 Mn |
| Jun 30, 2023 | 385.67 Mn |
| Mar 31, 2023 | 379.95 Mn |
| Dec 31, 2022 | 380.14 Mn |
| Sep 30, 2022 | 378.30 Mn |
| Jun 30, 2022 | 365.47 Mn |
| Mar 31, 2022 | 369.70 Mn |
| Dec 31, 2021 | 340.35 Mn |
| Sep 30, 2021 | 337.41 Mn |
| Jun 30, 2021 | 342.42 Mn |